Schizophrenia
Item
satisfying international classification of disease-10 (icd) diagnostic criteria of schizophrenia;
boolean
C0036341 (UMLS CUI [1])
Positive and Negative Syndrome Scale Clinical Classification
Item
positive and negative syndrome scale (panss) total score ≥ 60
boolean
C4086747 (UMLS CUI [1])
Refractory schizophrenia | Clozapine failed
Item
refractory schizophrenia or patients treated with sufficient clozapine for a minimum period of 6-8 weeks without improvement;
boolean
C2063865 (UMLS CUI [1])
C0009079 (UMLS CUI [2,1])
C0231175 (UMLS CUI [2,2])
Study Subject Participation Status
Item
participation into another clinical trial within the last month;
boolean
C2348568 (UMLS CUI [1])
Amisulpride
Item
patients previously or currently treated with amisulpride;
boolean
C0103045 (UMLS CUI [1])
Clozapine | Antipsychotic Agents Active Long-term
Item
patients receiving clozapine within the past 1 month or treated with long-acting formulation of antipsychotic medication within the past 2 months;
boolean
C0009079 (UMLS CUI [1])
C0040615 (UMLS CUI [2,1])
C0205177 (UMLS CUI [2,2])
C0443252 (UMLS CUI [2,3])
Electroconvulsive Therapy | Physical therapy
Item
patients receiving electric convulsive therapy or physical therapy within the past 1 month;
boolean
C0013806 (UMLS CUI [1])
C0949766 (UMLS CUI [2])
Comorbidity Systemic Severe
Item
patients with coexisting severe systemic diseases;
boolean
C0009488 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
Study Subject Participation Status Considerations Additional
Item
the above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
boolean
C2348568 (UMLS CUI [1,1])
C0518609 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])